Chemistry: molecular biology and microbiology – Treatment of micro-organisms or enzymes with electrical or... – Modification of viruses
Patent
1989-11-13
1996-08-27
Fleisher, Mindy
Chemistry: molecular biology and microbiology
Treatment of micro-organisms or enzymes with electrical or...
Modification of viruses
4353201, 435212, 435 691, 530380, 536 232, 536 235, C12N 1501, C12N 1563, C12N 950, C07H 2104
Patent
active
055500420
ABSTRACT:
The present invention relates to serine protease mutants of the chymotrypsin superfamily that are resistant to inhibition by their cognate inhibitors, and genes that encode the same. The present invention also relates to serine protease inhibitor mutants that inhibit the serine protease mutants of the present invention, and genes that encode the same. The serine protease, mutants and serine protease inhibitor mutants are useful as, e.g., pharmacological agents.
REFERENCES:
patent: 5073494 (1991-12-01), Heyneker et al.
patent: 5108901 (1992-04-01), Anderson et al.
patent: 5200340 (1993-04-01), Foster et al.
patent: 5262170 (1993-11-01), Anderson
patent: 5405771 (1995-04-01), Anderson
Bergum et al, "Neutralization by Plasmiogen Activator Inhibitor-1 of Mutants of Tissue Plasminogen Activator", Enzyme, 40:122-129 (1988).
Haigwood et al, "Improvements of T-PA Properties by Means of Site directed Mutagenesis", Throm Haemostas, 58:1042 (1987).
Read, R. J. et al, In: Proteinase Inhibitors, Ed. Barret, A. J. et al, Elsevier, Amsterdam, pp. 301-336 (1986).
Blundell, T. et al, Nature, 326:347-352 (1987).
Huber, R. et al, J. Mol. Biol., 89:73-101 (1974).
Bode, W. et al, In: Proteolysis and Physiological Regulation, Academic Press, New York, pp. 43-76 (1976).
Greer, Proteins: Structure, Function, and Genetics, 7:317-334 (1990).
Swindells et al, Current Opinion in Biotechnology, 2:512-519 (1991).
Argos et al, Protein Engineering, 4:375-383 (1991).
Rastetter, Trends in Biotechnology, 1:80-84 (1983).
Ackers et al, Ann. Rev. Biochem., 54:597-629 (1985).
Rickles et al, J. Biol. Chem., 263:1563-1569 (1988).
Gardell et al, J. Biol. Chem., 264:17947-17952 (1989).
Belin et al, Eur. J. Biochem., 148:225-232 (1985).
Bennett et al, J. Biol. Chem., 266:1-11 (1991).
Adams et al, J. Biol. Chem., 266:8476-8482 (1991).
Madison et al, Nature, 339:721-723 (Jun. 1989).
Madison et al J. Biol. Chem., 265:21423-21426 (Dec. 1990).
Larsen et al, Current Opinion in Biotechnology, 2:220-226 (1991).
Ringe, Nature, 339:658-659 (1989).
Barrett et al, Eds., Proteinase Inhibitors, Elsevier Science Publishers (Amsterdam), pp. 403-420 (1986).
Kraut, Ann. Rev. Biochem., 46:311-358 (1977).
Matheson et al, J. Biol. Chem., 261:10404-10409 (1986).
Strassburger et al, FEBS Lett., 157:219-223 (1983).
Holmes et al, Biochem., 26:5133-5140 (1987).
Schapira et al, J. Clin. Invest., 76:635-637 (1985).
Owen et al, New Eng., J. Med., 309:694-698 (1983).
Braun et al, Biochem., 27:6517-6524 (1988).
Schapira et al, J. Clin. Invest., 80:582-585 (1987).
Gerard Robert D.
Gething Maryjane H.
Goldsmith Elizabeth J.
Madison Edwin L.
Sambrook Joseph F.
Degen Nancy J.
Fleisher Mindy
The Board of Regents of the University of Texas System
LandOfFree
Serine protease mutants of the chymotrypsin superfamily resistan does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Serine protease mutants of the chymotrypsin superfamily resistan, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Serine protease mutants of the chymotrypsin superfamily resistan will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1055825